Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Salvage Radiotherapy for Nodal Oligorecurrent Prostate Cancer: A Step Towards Predictive Criteria for Metastasis-Directed Therapy in Prostate Cancer?

Desai NB, Courtney K, Subramaniam RM, Cadeddu JA.

Eur Urol. 2019 Aug 14. pii: S0302-2838(19)30611-6. doi: 10.1016/j.eururo.2019.07.050. [Epub ahead of print] No abstract available.

PMID:
31421942
2.

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).

Kapoor R, Deek MP, McIntyre R, Raman N, Kummerlowe M, Chen I, Gaver M, Wang H, Denmeade S, Lotan T, Paller C, Markowski M, Carducci M, Eisenberger M, Beer TM, Song DY, DeWeese TL, Hearn JW, Greco S, DeVille C, Desai NB, Heath EI, Liauw S, Spratt DE, Hung AY, Antonarakis ES, Tran PT.

BMC Cancer. 2019 Jun 13;19(1):572. doi: 10.1186/s12885-019-5805-z.

3.

Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer.

Atluri PS, Gannavarapu BS, Timmerman RD, Garant A, Hannan R, Folkert MR, Desai NB.

Pract Radiat Oncol. 2019 Jun 4. pii: S1879-8500(19)30159-6. doi: 10.1016/j.prro.2019.05.013. [Epub ahead of print]

PMID:
31173917
4.

Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis.

Satyanarayan A, Mooney R, Bhanvadia RR, Iyengar P, Margulis V, Desai NB, Bagrodia A.

Clin Genitourin Cancer. 2019 Aug;17(4):e768-e771. doi: 10.1016/j.clgc.2019.04.005. Epub 2019 Apr 26. No abstract available.

PMID:
31109801
5.

Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure.

Jackson WC, Suresh K, Tumati V, Dess RT, Soni PD, Zhao SG, Zumsteg ZS, Hannan R, Hollenbeck BK, George A, Kaffenberger SD, Salami SS, Hearn JWD, Morgan TM, Mehra R, Schipper M, Feng FY, Desai NB, Spratt DE.

Eur Urol Oncol. 2018 Sep;1(4):276-282. doi: 10.1016/j.euo.2018.04.014. Epub 2018 Sep 28.

PMID:
31100248
6.

Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.

Zhang M, Yang TJ, Desai NB, DeLair D, Kollmeier MA, Makker V, Leitao MM Jr, Abu-Rustum NR, Alektiar KM.

Brachytherapy. 2019 Jan - Feb;18(1):38-43. doi: 10.1016/j.brachy.2018.08.015. Epub 2018 Oct 10.

PMID:
30316723
7.

Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.

Leiker AJ, Desai NB, Folkert MR.

Future Oncol. 2018 Nov;14(26):2773-2788. doi: 10.2217/fon-2018-0286. Epub 2018 Jun 25. Review.

PMID:
29939069
8.

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy.

Mohamad O, Diaz de Leon A, Schroeder S, Leiker A, Christie A, Zhang-Velten E, Trivedi L, Khan S, Desai NB, Laine A, Albuquerque K, Iyengar P, Arriaga Y, Courtney K, Gerber DE, Hammers H, Choy H, Timmerman R, Brugarolas J, Hannan R.

Oncoimmunology. 2018 Mar 15;7(7):e1440168. doi: 10.1080/2162402X.2018.1440168. eCollection 2018.

9.

Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy.

Tumati V, Trivedi L, Li HC, Patel P, Scaglioni PP, Vusirikala M, Sadeghi N, Rizvi S, Chen W, Wachsmann J, Collins R Jr, Desai NB.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1126-1132. doi: 10.1016/j.ijrobp.2018.01.041. Epub 2018 Jan 31.

PMID:
29722657
10.

Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival.

Jackson WC, Suresh K, Tumati V, Allen SG, Dess RT, Salami SS, George A, Kaffenberger SD, Miller DC, Hearn JWD, Jolly S, Mehra R, Hollenbeck BK, Palapattu GS, Schipper M, Feng FY, Morgan TM, Desai NB, Spratt DE.

Eur Urol. 2018 Oct;74(4):413-419. doi: 10.1016/j.eururo.2017.12.023. Epub 2018 Jan 3.

PMID:
29306514
11.

Angiosarcoma of the right atrium and right ventricle.

Rao JN, Gowda G D, Anand R, Desai NB.

J Card Surg. 2017 Dec;32(12):807-808. doi: 10.1111/jocs.13381. Epub 2017 Dec 12. No abstract available.

PMID:
29230880
12.

Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.

Chang MT, Penson A, Desai NB, Socci ND, Shen R, Seshan VE, Kundra R, Abeshouse A, Viale A, Cha EK, Hao X, Reuter VE, Rudin CM, Bochner BH, Rosenberg JE, Bajorin DF, Schultz N, Berger MF, Iyer G, Solit DB, Al-Ahmadie HA, Taylor BS.

Clin Cancer Res. 2018 Apr 15;24(8):1965-1973. doi: 10.1158/1078-0432.CCR-17-2655. Epub 2017 Nov 27.

13.

Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.

Jones RT, Hassan Rezaeian N, Desai NB, Lotan Y, Jia X, Hannan R, Kim DWN, Hornberger B, Dubas J, Laine AM, Zelefsky MJ, Timmerman RD, Folkert MR.

Med Dosim. 2017 Winter;42(4):341-347. doi: 10.1016/j.meddos.2017.07.002. Epub 2017 Jul 31.

PMID:
28774760
14.

Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.

Yin Y, Li R, Xu K, Ding S, Li J, Baek G, Ramanand SG, Ding S, Liu Z, Gao Y, Kanchwala MS, Li X, Hutchinson R, Liu X, Woldu SL, Xing C, Desai NB, Feng FY, Burma S, de Bono JS, Dehm SM, Mani RS, Chen BPC, Raj GV.

Cancer Res. 2017 Sep 15;77(18):4745-4754. doi: 10.1158/0008-5472.CAN-17-0164. Epub 2017 Jul 28.

15.

Erectile function after stereotactic body radiotherapy for localized prostate cancer.

Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, Spratt DE.

BJU Int. 2018 Jan;121(1):61-68. doi: 10.1111/bju.13962. Epub 2017 Aug 17.

16.

Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution study.

Tumati V, Jackson WC, Abugharib AE, Raj G, Roehrborn C, Lotan Y, Courtney K, Bagrodia A, Gahan JC, Zumsteg ZS, Folkert MR, Laine AM, Hannan R, Spratt DE, Desai NB.

BJU Int. 2018 Mar;121(3):365-372. doi: 10.1111/bju.13926. Epub 2017 Jul 5.

17.

Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.

Jackson WC, Desai NB, Abugharib AE, Tumati V, Dess RT, Lee JY, Zhao SG, Soliman M, Folkert M, Laine A, Hannan R, Zumsteg ZS, Sandler H, Hamstra DA, Montgomery JS, Miller DC, Kozminski MA, Hollenbeck BK, Hearn JW, Palapattu G, Tomlins SA, Mehra R, Morgan TM, Feng FY, Spratt DE.

BJU Int. 2017 Sep;120(3):351-357. doi: 10.1111/bju.13792. Epub 2017 Feb 26.

18.

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

Desai NB, Laine AM, Timmerman RD.

Br J Radiol. 2017 Feb;90(1070):20160500. doi: 10.1259/bjr.20160500. Epub 2016 Dec 23. Review.

19.

Genomic characterization of response to chemoradiation in urothelial bladder cancer.

Desai NB, Scott SN, Zabor EC, Cha EK, Hreiki J, Sfakianos JP, Ramirez R, Bagrodia A, Rosenberg JE, Bajorin DF, Berger MF, Bochner BH, Zelefsky MJ, Kollmeier MA, Ostrovnaya I, Al-Ahmadie HA, Solit DB, Iyer G.

Cancer. 2016 Dec 1;122(23):3715-3723. doi: 10.1002/cncr.30219. Epub 2016 Aug 1.

20.

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan EJ, Gao SP, Ramirez R, Cha EK, Desai NB, Zabor EC, Ostrovnaya I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale A, Arcila ME, Dalbagni G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor BS, Solit DB.

Nat Genet. 2016 Apr;48(4):356-8. doi: 10.1038/ng.3503. Epub 2016 Feb 22.

21.

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma.

Bagrodia A, Cha EK, Sfakianos JP, Zabor EC, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA, Iyer G, Scott SN, Shah R, Ostrovnaya I, Lee B, Desai NB, Ren Q, Rosenberg JE, Dalbagni G, Bajorin DF, Reuter VE, Berger MF; Collaborators.

J Urol. 2016 Jun;195(6):1684-1689. doi: 10.1016/j.juro.2016.01.006. Epub 2016 Jan 14.

22.

Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.

Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN.

J Clin Oncol. 2016 Jan 10;34(2):123-9. doi: 10.1200/JCO.2015.62.0138. Epub 2015 Oct 5.

23.

Genomic Characterization of Upper Tract Urothelial Carcinoma.

Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH, Ren Q, Bagrodia A, Kim PH, Hakimi AA, Ostrovnaya I, Ramirez R, Hanrahan AJ, Desai NB, Sun A, Pinciroli P, Rosenberg JE, Dalbagni G, Schultz N, Bajorin DF, Reuter VE, Berger MF, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA.

Eur Urol. 2015 Dec;68(6):970-7. doi: 10.1016/j.eururo.2015.07.039. Epub 2015 Aug 14.

24.

Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.

Desai NB, Kollmeier MA, Makker V, Levine DA, Abu-Rustum NR, Alektiar KM.

Gynecol Oncol. 2014 Oct;135(1):49-53. doi: 10.1016/j.ygyno.2014.07.097. Epub 2014 Jul 30.

PMID:
25084509
25.

Modeling positioning uncertainties of prostate cancer external beam radiation therapy using pre-treatment data.

Munck af Rosenschöld P, Desai NB, Oh JH, Apte A, Hunt M, Kalikstein A, Mechalakos J, Happersett L, Deasy JO, Zelefsky MJ.

Radiother Oncol. 2014 Feb;110(2):251-5. doi: 10.1016/j.radonc.2013.12.010. Epub 2014 Feb 20.

26.

Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.

Desai NB, Kiess AP, Kollmeier MA, Abu-Rustum NR, Makker V, Barakat RR, Alektiar KM.

Gynecol Oncol. 2013 Dec;131(3):604-8. doi: 10.1016/j.ygyno.2013.09.019. Epub 2013 Sep 20.

PMID:
24055615
27.

Aorto-left atrial tunnel: a rare entity.

Paul SK, Gajjar TP, Desai NB.

Ann Thorac Surg. 2013 May;95(5):e121-2. doi: 10.1016/j.athoracsur.2012.11.009.

PMID:
23608293
28.

Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.

Desai NB, Stein NF, LaQuaglia MP, Alektiar KM, Kushner BH, Modak S, Magnan HM, Goodman K, Wolden SL.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e67-72. doi: 10.1016/j.ijrobp.2012.09.005. Epub 2012 Oct 17.

PMID:
23084475
29.

Repair of a distal ductal origin of the left pulmonary artery associated with a ventricular septal defect.

Gajjar TP, Desai NB.

J Card Surg. 2012 Sep;27(5):625-9. doi: 10.1111/j.1540-8191.2012.01506.x.

PMID:
22978842
30.

True aneurysm of anterior mitral leaflet--a rare entity.

Gajjar TP, Desai NB.

J Thorac Cardiovasc Surg. 2012 Sep;144(3):e93-5. doi: 10.1016/j.jtcvs.2012.05.055. Epub 2012 Jun 15. Review. No abstract available.

31.

Giant ventricular myxoma obstructing right ventricular outflow tract.

Gajjar TP, Shah GB, Desai NB.

Rev Bras Cir Cardiovasc. 2011 Oct-Dec;26(4):663-6.

PMID:
22358285
32.

Echocardiographic diagnosis and surgical closure of coronary sinus type of atrial septal defect.

Gajjar TP, Rao JN, Desai NB.

J Card Surg. 2011 Nov;26(6):653-6. doi: 10.1111/j.1540-8191.2011.01340.x.

PMID:
22122378
33.

Surgical closure of sinus venosus atrial septal defect using a single patch--transcaval repair technique.

Gajjar TP, Hiremath CS, Desai NB.

J Card Surg. 2011 Jul;26(4):429-34. doi: 10.1111/j.1540-8191.2011.01270.x.

PMID:
21793931
34.

Bicameral repair of right pulmonary artery to left atrial communication.

Gajjar TP, Desai NB.

Thorac Cardiovasc Surg. 2012 Apr;60(3):229-32. doi: 10.1055/s-0030-1271183. Epub 2011 Jun 20.

PMID:
21692017
35.

Bexarotene and erlotinib for aerodigestive tract cancer.

Dragnev KH, Petty WJ, Shah S, Biddle A, Desai NB, Memoli V, Rigas JR, Dmitrovsky E.

J Clin Oncol. 2005 Dec 1;23(34):8757-64.

PMID:
16314636
36.

Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.

Petty WJ, Dragnev KH, Memoli VA, Ma Y, Desai NB, Biddle A, Davis TH, Nugent WC, Memoli N, Hamilton M, Iwata KK, Rigas JR, Dmitrovsky E.

Clin Cancer Res. 2004 Nov 15;10(22):7547-54.

37.

Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.

Dragnev KH, Pitha-Rowe I, Ma Y, Petty WJ, Sekula D, Murphy B, Rendi M, Suh N, Desai NB, Sporn MB, Freemantle SJ, Dmitrovsky E.

Clin Cancer Res. 2004 Apr 1;10(7):2570-7.

38.

Myxoma producing right-sided inflow and outflow obstruction.

Krishnamoorthy KM, Desai NB.

Int J Cardiol. 2001 Jul;79(2-3):325-6. No abstract available.

PMID:
11488289
39.

Left ventricular aneurysm: angiographic determinants.

Jagtap PM, Desai NB, Bansal NO, Vaidya SV, Pathak L.

J Assoc Physicians India. 1995 May;43(5):331-3.

PMID:
9081962
40.

Unusual presentation of aneurysm of aorta.

Pande AK, Ambardekar SS, Desai NB, Tulpule AT, Pathak L, Goyal BK.

J Assoc Physicians India. 1989 Jun;37(6):387-8.

PMID:
2592331
41.

Closed mitral valvotomy: a second look.

Pande AK, Pendkar RG, Desai NB, Ambardekar SS, Kumar A, Tulpule AT, Pathak L, Mehta VI, Goyal BK.

Indian Heart J. 1985 Nov-Dec;37(6):386-9. No abstract available.

PMID:
3836943

Supplemental Content

Loading ...
Support Center